Corcept Therapeutics | CORT - Le Coût Des Ventes





Le Coût Des Ventes Changement Date
Acadia Pharmaceuticals USD 24.79M 1.43M 2026-03
Alaunos Therapeutics USD 0 18K 2024-09
ANI Pharmaceuticals USD 114.5M 8.38M 2026-03
Ardelyx USD 10.85M 6.87M 2025-12
Assertio Holdings USD 8.89M 2.29M 2024-06
Aurora Cannabis CAD 88.61M 30.53M 2025-12
BioMarin Pharmaceutical USD 199.48M 37.93M 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Canopy Growth CAD 53.08M 8.3M 2025-12
Corcept Therapeutics USD 2.88M 338K 2026-03
Eli Lilly USD 3.58B 205M 2026-03
Esperion Therapeutics USD 27.85M 13.43M 2025-12
J&J USD 8.07B 103M 2026-03
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Lexicon Pharmaceuticals USD 201K 191K 2025-12
Merck USD 2.94B 380M 2026-03
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Novartis USD 3.46B 83M 2026-03
Novartis USD 3.54B 7M 2025-12
Omeros USD 33.16M 18.52M 2024-06
Pacira USD 50.74M 3.89M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
Supernus Pharmaceuticals USD 49.04M 1.5M 2026-03
TG Therapeutics USD 33.51M 4.63M 2026-03